The Undersea Medicine program is one of five ONR National Naval Responsibilities. The aim of Undersea Medicine is to develop science and technology solutions that optimize diver and submariner performance and enhance the flexibility, efficiency and safety of undersea warfighter missions. An important result of this program is to enable safe submarine escape and rescue operations. Solutions should extend the warfighter's reach and allow freedom of action in the water column, thermal extremes and in contaminated water. Solutions from diverse areas such as biological, computer and behavioral sciences are encouraged, with the objective of developing improved methods, models, treatments and devices for understanding, preventing or mitigating adverse health effects (including psychological) that negatively impact diving and submarine operations.
Program interests currently include, but are not limited to, understanding the pathology and etiology of decompression illnesses (DCI, i.e., decompression sickness and arterial/venous gas embolism), hyperbaric oxygen toxicity, nitrogen narcosis and high-pressure nervous syndrome; nonrecompressive prevention and treatment of DCI; identifying potential long-term health effects of diving and exposure to submarine environment; safe diving in contaminated water; underwater human-systems interface; improvements in diver and submarine crew human performance; and undersea biometric monitoring.
Long Range Broad Agency Announcement (BAA) for Navy and Marine Corps Science and Technology BAA N00014-16-R-BA01
N00014-16-R-BA001.pdf (PDF - 463.41 KB)
Amendment 0001 (PDF - 462.24 KB)
Amendment 0002 (PDF - 370.21 KB)
BAA N00014-16-R-BA01 Amendment 0003 (PDF - 369.79 KB)
BAA N00014-16-R-BA01 Amendment 0004 (PDF - 370.59 KB)
N00014-16-R-BA01 Amendment 0005 (PDF - 480.53 KB)
N00014-16-R-BA01 Amendment 0006 (PDF - 488.32 KB) Updates to BAA
Published: October 1, 2015 12:15 PM EST | Full Proposals will be accepted until September 30, 2016 05:00 PM EST